ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Mardia Samyoung Capillary Tubes Company Limited has issued its Annual Report and notice for the 34th Annual General Meeting scheduled for September 29, 2026.
Mardia Samyoung Capillary Tubes Company scheduled a board meeting for September 03, 2026, to discuss the AGM date and shifting the registered office to Gujarat.
Mardia Samyoung Capillary Tubes Company Ltd has launched its new functional website following its acquisition under a liquidation process. The website will facilitate mandatory SEBI LODR disclosures.
Mardia Samyoung Capillary Tubes Company Ltd reported revenue from operations of ₹24.8 Cr and net profit of ₹1.1 Cr for Q1 FY27.
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended June 30, 2026.
Mardia Samyoung Capillary Tubes Company Ltd has scheduled a board meeting on August 11, 2026. The board will consider and approve unaudited financial results for June 2026.
Mardia Samyoung Capillary Tubes Company Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, as per SEBI regulations.
Mardia Samyoung Capillary Tubes Company updated its Corporate Identification Number to L20132MH1992PLC069104 on the MCA portal. This administrative change ensures regulatory records align with recent company revisions.
Mardia Samyoung Capillary Tubes Company Ltd reported revenue from operations of ₹61.1 Cr and net profit of ₹1.1 Cr for Q4 FY26.
Mardia Samyoung confirmed it is not classified as a Large Corporate for the financial year 2026. This regulatory filing follows nil outstanding borrowings as of year-end.
Mardia Samyoung Capillary Tubes reported zero deviation in the utilization of preferential issue proceeds for March 2026. The company confirmed all raised funds were fully utilized.
Mardia Samyoung Capillary Tubes approved its audited financial results for the year ended March 31, 2026. The board confirmed unmodified audit opinions for the reporting period.
Mardia Samyoung Capillary Tubes scheduled a board meeting for May 12, 2026. Directors will consider and approve audited financial results for the period ended March 2026.
Mardia Samyoung Capillary Tubes Company Ltd's board approved the appointment of Mr. Ramesh Sharma and Ms. Geetika Garg as Independent Directors. Simultaneously, Ms. Sonalben Vaghela and Mr. Jaykumar Patel resigned from the board. These changes led to the reconstitution of the Audit, Nomination & Remuneration, and Stakeholder Relationship committees effective May 6, 2026.
Mardia Samyoung Capillary Tubes Company Ltd has allotted 39,00,000 equity shares following the conversion of warrants by Mr. Gavali Hitendrabhai Bayajebhai. The transaction, valued at ₹5.26 Crore, increases the company's paid-up equity capital to INR 79.45 Crore. This conversion represents a significant equity infusion from a non-promoter investor.
Mardia Samyoung Capillary Tubes Company Ltd reported net profit of ₹1.3 Cr for Q3 FY26.
Mardia Samyoung Capillary Tubes Company Ltd allotted 78,15,000 equity shares following the conversion of warrants issued at ₹13.50 each. The allotment, worth ₹10.55 Crore, was made to non-promoter individuals Patel Biralkumar Rajeshbhai and Shaikh Sajidbhai Rahimbhai. This transaction increases the company's paid-up equity capital to ₹75.55 Crore.